Clinical Resources

MDS African Parkinson’s Disease and Movement Disorders Conference (APMC)

In-Person

Nairobi

Mar 10, 2026 - Mar 11, 2026

Experienced / Intermediate, Expert / Advanced

1065<p>The MDS African Parkinson&rsquo;s Disease and Movement Disorders Conference (APMC) brings together clinicians and researchers for practical, skills-based education in Movement Disorders across Africa. The program features interactive workshops on clinical evaluation and genetic testing, expert-led sessions on Parkinson&rsquo;s disease in Africa, acquired Movement Disorders, multidisciplinary care, and emerging topics, as well as a panel highlighting successful African collaborations and the history of MDS in the region.</p><p><span style="font-size:11.0pt;">&nbsp;</span></p>Ataxias, Biomarkers, Biomarkers & Diagnostic Tools, Botulinum toxin, Chorea/Huntingtons Disease (HD), Dopaminergic medications, Drug-induced Movement Disorders/Tardive dyskinesia, Dystonia, Epidemiology, Epidemiology & Environment, Functional Movement Disorders, Genetic & Hereditary Disorders, Genetics, Hyperkinetic Movement Disorders, Infusion therapy, Movement Disorders Emergencies, Myoclonus, Neuroimaging, Occupational Therapy, Other Movement Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Physical Therapy/Physiotherapy, Rare/Uncommon Movement Disorders, Risk Factors, Speech Therapy, Therapies-Other, Therapies-Pharmacological, Tics/Tourettes syndrome (TS), Toxic Exposures, Tremor/Essential Tremor (ET)11700.00https://education.movementdisorders.org/Detail/1065/MDS-African-Parkinson’s-Disease-and-Movement-Disorders-Conference-(APMC)https://education.movementdisorders.org/Upload/ActivityImages/26AFRGP2_202x108872238.png2026-03-10T00:00:002026-03-11T00:00:00Nairobi<p><br></p><p><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/GP2_21032024044229.jpg" style="width: 300px;" class="fr-fic fr-dib"></p><p><br></p><p><em>Supported in part by the Global Parkinson&rsquo;s Genetics Program, a program of the Aligning Science Across Parkinson&rsquo;s initiative and implemented by the Michael J. Fox Foundation</em>&nbsp;</p>MDS Education<p><strong><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Course schedule_13052025105320.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></strong><a href="https://execinccom-my.sharepoint.com/:b:/g/personal/treed_execinc_com/IQAvqCvtlpBmToS__-CFui8FAduQ8J99btMR7cdwebamehY?e=3kBHOK" rel="noopener noreferrer" target="_blank"><strong>&nbsp;Conference Schedule&nbsp;</strong>&nbsp;</a><a href="https://form.jotform.com/260055452458154" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Travel assistance_23012024043912.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://form.jotform.com/260055452458154" rel="noopener noreferrer" target="_blank"><strong>Travel Bursary&nbsp;</strong></a><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"><a href="https://execinccom-my.sharepoint.com/:b:/g/personal/treed_execinc_com/IQDMRugTFGYUSrVU8O2UfW-AARfoNV0sgXVYUrw1ojNOZpo?e=O5Rd8T" rel="noopener noreferrer" target="_blank"><strong>Conference</strong><strong>&nbsp;Faculty</strong></a></p><p><br></p><p><em>Program&nbsp;</em>S<em>chedule will be shared in the coming week</em></p><p><strong><em><span style="color: rgb(175, 38, 38);">Application/Travel Bursary Deadline:</span>&nbsp;</em></strong><em>January 22</em><em>, 2026</em></p><p><em>*Limited Spaces Available*</em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br>Complimentary registration provided to those accepted.</p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf"><em>Click here to view the MDS Regional Course Cancellation Policy &amp; Visa Assistance Information</em></a></p><p><br></p><p><strong>SCIENTIFIC PLANNING COMMITTEE</strong></p><p>Ali Shalash, MD, PhD&nbsp;</p><p>Nijedka Okubadejo, MD, FMCP, FAAN, FANA</p><p>Oluwadamilola Ojo, MBBS, MD, FMCP</p><p>Samia ben Sassi, MD</p><p>Maouly Fall, MD</p><p>Yared Zewde, MD</p><p>Daniel Gams Massi, MD</p><p>Jonathan Carr, MBChB, PhD</p><p>Mary Agoriwo, MSc, PhD (C)</p><p>Houyam Tibar, Associate Professor</p><p>Juzar Hooker, MB ChB MMed DCN FCP&nbsp;</p><p>Dilraj S. Sokhi, FRCP(Edin)</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><ol><li data-end="386" data-start="223"><p data-end="386" data-start="226">Apply a structured clinical approach to evaluating Movement Disorders, including the differentiation of parkinsonism, hyperkinetic disorders, and ataxias.</p></li><li data-end="536" data-start="388"><p data-end="536" data-start="391">Identify appropriate indications and strategies for genetic testing in Movement Disorders, including recognition of key clinical red flags.</p></li><li data-end="735" data-start="538"><p data-end="735" data-start="541">Describe the genetic, environmental, and clinical factors influencing Parkinson&rsquo;s disease in Africa, and discuss practical strategies for diagnosis and management in low-resource settings.</p></li><li data-end="878" data-start="737"><p data-end="878" data-start="740">Recognize and manage major categories of acquired Movement Disorders, including infectious, autoimmune, and drug-induced conditions.</p></li><li data-end="1060" data-start="880"><p data-end="1060" data-start="883">Implement multidisciplinary, patient-centered approaches to Movement Disorders care, including the management of emergencies, functional disorders, and rehabilitation needs.</p></li></ol><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>The MDS African Parkinson&rsquo;s Disease and Movement Disorders Conference (APMC) is designed for experienced and expert clinicians, researchers, and trainees involved in Movement Disorders care across Africa who seek to strengthen their clinical knowledge, practical skills, and understanding of regional diagnostic and multidisciplinary care approaches.</p>Nairobi0/Courses/MDS-African-Parkinsons-Disease-and-Movement-Disorders-Conference-APMC.htmMDS African Parkinson’s Disease and Movement Disorders Conference (APMC)2026-01-07T12:01:03.13000Experienced / IntermediateExpert / AdvancedIn-PersonBiomarkers &amp; Diagnostic ToolsEpidemiology &amp; EnvironmentHyperkinetic Movement DisordersOther Movement DisordersParkinson Disease/Hypokinetic Movement DisordersTherapies-OtherTherapies-Pharmacological

Journal CME 40.12: Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial

On Demand

60 Minutes

Experienced / Intermediate

1064<p>The Journal CME 40.12 article aims to evaluate the effects of a probiotic (Lacticaseibacillus rhamnosus, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Enterococcus faecium) on gut microbiota, inflammation, motor and non-motor symptoms (NMS) in PwP and constipation.</p>Etiology & Pathophysiology, Microbiome, Nutritional Therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-OtherValentina Leta, PhD601.00https://education.movementdisorders.org/Detail/1064/Journal-CME-40-12:-Effects-of-a-Four-Strain-Probiotic-on-Gut-Microbiota,-Inflammation,-and-Symptoms-in-Parkinson's-Disease:-A-Randomized-Clinical-Trialhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-12-18T00:00:002026-12-18T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.12%20-%20Disclosures_17122025024322.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p><span style="color: rgb(0, 0, 0);">1. Understand the role of gut dysbiosis in Parkinson&rsquo;s disease</span></p><p><span style="color: rgb(0, 0, 0);">2. Assess the impact of a four-strain probiotic on microbiota, inflammation, and symptoms</span></p><p><span style="color: rgb(0, 0, 0);">3. Evaluate the clinical value of probiotics as an adjunct therapy in Parkinson&rsquo;s disease</span></p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.12-Effects-of-a-Four-Strain-Probiotic-on-Gut-Microbiota-Inflammation-and-Symptoms-in-Parkinsons-Disease-A-Randomized-Clinical-Trial.htmJournal CME 40.12: Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical TrialJournal CME 40.122025-12-18T15:01:04.61700Experienced / IntermediateOn-DemandEtiology &amp; PathophysiologyParkinson Disease/Hypokinetic Movement DisordersTherapies-Other

Journal CME 40.11: Waveform-Based Analysis of Head Tremor Using a Marker-Less Tracking Algorithm with 2D-Video: Evaluation of Sinusoidality and Rhythmicity

On Demand

60 Minutes

Experienced / Intermediate

1059<p>The Journal CME 40.11 article aims to introduce a novel video-based waveform analysis to objectively measure two fundamental tremor characteristics&mdash;rhythmicity and sinusoidality.</p>Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Rating Scales, Tremor/Essential Tremor (ET)Jung Hwan Shin, MD, PhD601.00https://education.movementdisorders.org/Detail/1059/Journal-CME-40-11:-Waveform-Based-Analysis-of-Head-Tremor-Using-a-Marker-Less-Tracking-Algorithm-with-2D-Video:-Evaluation-of-Sinusoidality-and-Rhythmicityhttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-11-26T00:00:002026-11-26T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.11%20-%20Disclosures_25112025025555.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of rhythmicity and sinusoidality in differentiating tremor types using video-based waveform analysis</p><p>2. Assess the reliability of video-based indices in measuring tremor characteristics by comparing them to gyroscope-based data</p><p>3. Evaluate the effectiveness of video-based analysis in distinguishing between cervical dystonia and essential tremor based on rhythmicity and sinusoidality indices</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.11-Waveform-Based-Analysis-of-Head-Tremor-Using-a-Marker-Less-Tracking-Algorithm-with-2D-Video-Evaluation-of-Sinusoidality-and-Rhythmicity.htmJournal CME 40.11: Waveform-Based Analysis of Head Tremor Using a Marker-Less Tracking Algorithm with 2D-Video: Evaluation of Sinusoidality and RhythmicityJournal CME 40.112025-11-26T12:01:08.62700Experienced / IntermediateOn-DemandBiomarkers &amp; Diagnostic ToolsHyperkinetic Movement Disorders

MDS Case Presentation: Hyperkinetic Disorder in a 9 Year-Old Boy

On Demand

15 Minutes

Foundational / Beginner

941This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case of a 9 year-old patient with hyperkinetic disorder.Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Deep brain stimulation, Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Medications for motor symptoms, Medications for non-motor symptoms, Neuroimaging, Neuropathology, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Rating Scales, Therapies-Pharmacological, Therapies-SurgicalAlia Mansour, PhD150.00https://education.movementdisorders.org/Detail/941/MDS-Case-Presentation:-Hyperkinetic-Disorder-in-a-9-Year-Old-Boyhttps://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg2025-11-18T00:00:002028-11-18T00:00:00MDS Education<p><strong>FACULTY</strong></p><p>Alia Mansour, PhD - Ain Shams University, Cairo, Egypt</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/MDS-Case-Presentation-Hyperkinetic-Disorder-in-a-9-Year-Old-Boy.htmMDS Case Presentation: Hyperkinetic Disorder in a 9 Year-Old Boy2025-11-18T09:00:51.45000Foundational / BeginnerOn-DemandBiomarkers &amp; Diagnostic ToolsEtiology &amp; PathophysiologyGeneticsHyperkinetic Movement DisordersNon-motor Symptoms/DisordersTherapies-PharmacologicalTherapies-Surgical